Prudential Financial
INFI

Prudential Financial’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Prudential Financial’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-53,200
Closed -$29.5K – 2691
2022
Q4 		$29.5K Buy
53,200
+40,400
+316% +$34.4K ﹤0.01% 2544
2022
Q3 		$15K Buy
+12,800
New +$13.8K ﹤0.01% 2634
2015
Q4 		– Sell
-84,343
Closed -$713K – 2276
2015
Q3 		$713K Sell
84,343
-10,600
-11% -$97.8K ﹤0.01% 1865
2015
Q2 		$1.04M Sell
94,943
-83,000
-47% -$1.07M ﹤0.01% 1796
2015
Q1 		$2.49M Buy
+177,943
New +$2.72M ﹤0.01% 1488
2014
Q3 		– Sell
-10,025
Closed -$128K – 2329
2014
Q2 		$128K Buy
+10,025
New +$104K ﹤0.01% 2323

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial's INFI Position: Q1 2023 in Review

Prudential Financial sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 53,200 shares — an estimated $29.5K sold.

Prudential Financial first reported a position in INFI in Q2 2014 and held it in 6 quarters. The position peaked at $2.49M in Q1 2015. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

  • Prudential Financial reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Prudential Financial sold 53,200 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $29.5K.
  • Prudential Financial first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 6 quarters.
  • Prudential Financial's Infinity Pharmaceuticals, Inc. position peaked at $2.49M in Q1 2015.
  • 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on Prudential Financial's 13F filing for Q1 2023, filed 12 May 2023.